Dudediligence.

Black Hawk Acquisition Corporation

BKHANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

4.15M

on 2026-10-06, from 8.93M on 2024-06-28 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$200.0M

Agreement of 2026-09-22. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

The 10-Q filed 2026-07-15 is not read yet.

Cash

under 0.1 quarters

$0 on 2026-05-31 ÷ $139K a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-09-22Public offeringnot readnot readnot read424B4 ↗